A detailed history of Boothbay Fund Management, LLC transactions in Nevro Corp stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 861,857 shares of NVRO stock, worth $5.03 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
861,857
Holding current value
$5.03 Million
% of portfolio
0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$3.29 - $5.85 $2.84 Million - $5.04 Million
861,857 New
861,857 $5.03 Million
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $221,176 - $301,377
7,331 New
7,331 $265,000
Q2 2022

Aug 15, 2022

BUY
$40.85 - $77.67 $422,674 - $803,651
10,347 New
10,347 $454,000
Q3 2020

Nov 16, 2020

SELL
$114.09 - $145.51 $73.6 Million - $93.9 Million
-645,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$89.45 - $129.85 $57.7 Million - $83.8 Million
645,000 New
645,000 $886,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $207M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.